Campylobacter jejuni infection and treatment for Guillain-Barre syndrome [4]

New England Journal of Medicine

Volumn 335, Issue 3, 1996, Pages 208-209

  Jacobs, B C ^a   Schmitz, P I M ^a   Van der Meche, F G A ^a   Rees, J H ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE GM1; IMMUNOGLOBULIN; ANTIBODY;

BACTERIAL INFECTION; CAMPYLOBACTER JEJUNI; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GUILLAIN BARRE SYNDROME; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETTER; MAJOR CLINICAL STUDY; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; BLOOD; GRAM NEGATIVE INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; NOTE; POLYRADICULONEUROPATHY;

ANTIBODIES; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; G(M1) GANGLIOSIDE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PLASMA EXCHANGE; POLYRADICULONEUROPATHY; PROGNOSIS; TREATMENT OUTCOME;

EID: 0029666309     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199607183350315     Document Type: Letter

References (0)